Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes, Catt. If they are short, the share lenders will want their shares back. Unless they shorted their own shares, in which case they could just walk away, I believe. Shorting your own shares is really no different than having no position. Although there would be tax consequences.
Yes, we should all just ignore substance and allow short term manipulators to dictate our investment decisions. Good luck with that.
No question, Deck. Thin volume is the devil's playmate. With the warrants they always try to make you chase, whether you're buying or selling.
It is illegal in either arena, FBG. But what make's it really easy to prove in the case of the two knuckleheads is the manipulative intent of the trading, which is apparent from the fact that they created fictitious trading accounts and because normal people do not take both side of the market simultaneously. When mm's are involved it's more difficult to prove because they are, by nature, supposed to be taking both sides of the market. They deal in the stock. When it comes to the hedgies, they simply collude, with one acting as the "loser" and one taking the winning side. Then they return the shares to each other later, through dark pool trades, or by simply paying cash, or example. They also use patsy "street level" traders to act as the losers, and then pay them off in cash, etc.
That scheme is very analagous to what the mm's and hedgies do to manipulate stocks. Basically trading with themselves. Ever wonder why the HFT machines persistently trade 18 shares at a clip, at lower prices? Those are the "loser" trades aimed at getting the price moving down(see the article). They short before doing that, and then hope to induce others to start selling in the downtrend, so they can then cover. Then rinse and repeat. And the low volume is the key to the schemes. This whole "small time" scam was learned by these two guys from the "standard operating procedures" of today's highly-manipulated stock market.
New Jersey and Florida are the stock scammer capitals. I'm guessing he gets paid by Knight/EDGX, which is located very close to where he lives.
I hate to break this to you, but existing short positions do not place pressure on a stock. In fact, the opposite is true.
All incorrect statements. Except the net loss. It's a development-stage biotech company. Duh.
I agree, Catt. The other thing is, it's not easy for ADXS manipulators to cheat on each other to any significant extent, because with the lack of legitimate volume it would stick out like a sore thumb.
The common denominators in the coordinated manipulation are the mm's. Everything goes through them, and they have alot of control over the price and the direction. The other players do not need to discuss it, they see what is going on and they play ball. The thing is, when you get a de facto cartel working together to short/manipulate, at some point they start to cheat on each other like OPEC members secretly producing more oil than their allotment. One starts to cover, then another recognizes it, and then it steamrolls. That is when it starts to unravel. There is no honor among thieves.
Oh yeah, Blue. You have no idea who much I'd love to see the shorts take it in the shorts.
Bill, I just essentially said the same thing before reading your post. Exactly correct.
Blue, I've been saying for a while that the shorts have no legitimate short thesis. They simply counted on more shares becoming available to cover, which never really materialized. They didn't expect the resilience. So, due to the biotech weakness and the lack of volume, they just keep suppressing as best they can, for lack of a better plan. With the thinness of the market, if they even tried to cover 1 million shares the pps would probably jump 50%. In other words, they are trapped, and simply procrastinating, while making money trading the swings.
Exactly, Bill. That's why I say that the declines usually are not the result of real selling; it's all traders and manipulation (HFT and laddering down), exploiting the low "genuine" volume.
True, CrCook, but they also counted on getting shares back from somewhere, which they never really have gotten. Some retail shares, but very few big fish got out. Now they are simply playing a manipulation/waiting game. Waiting for what, I have no idea. I don't get it, personally.
Except that the FDA hold had no connection to the vaccine. Much ado about nothing . . .
Good, you saw that too, Bill. And let's not forget that Trump plans to streamline the U.S. FDA approval process. Given the efficacy results thus far and the excellent safety profile, AXAL SHOULD be approved sooner rather than later. Whether that happens is another story, but the benefits seem to outweigh the risks, and it is unwise to deny the world this treatment for a terminal disease.
I recall reading that the committee chairman that issues recommendations to the EMA had high praise for AXAL.
For a company with unapproved products and no real intent to go it alone? That's not unusual? I could see a BP building out well before a new product line gets approved, but a small pre-approval pharma like ADXS? Most of them don't even manufacture for themselves after approval.
No question, Blue. The stock is not behaving as it typically has been, which essentially means that the HFT manipulation pattern has changed, for whatever reason. Let's hope it's a good one.
Blue, ADXS more closely tracks the XBI than it does the IBB. It's not even in the IBB. Although both ETFs roughly track each other anyway.
Phyto, have you spoken to anyone when you visit ADXS? If so, what do they say?
From your mouth to God's ears . . . You are starting to sell me on this "waiting for a deal" scenario. I could see them simply delaying the announcement as opposed to delaying the dosing. Makes more sense.
Spill the beans, Phyto. What did you take away from it?
Billy, that is the case more often than not. Lots of fake trading in ADXS. The extent of mm/hedgie self-dealing, churning and laddering down has been ridiculous for months/years. The market is very thin, low float, not much real supply (or demand), very little "real" volume. It is the reason they have been able to move it around so much with little effort or risk. Basically, they are trading with themselves.
Sounds reasonable, Husker. Is it a fact that NEO will not be used for infectious diseases, though?
Why would NEO not apply to infectious disease? Seems to me that the personalization of the vaccine through NEO is directed more at triggering the immunoresponse in effective ways than it is personalized to the particular form of disease organism?
Are you saying they wouldn't honor their ask? Talk about cap 'n' trade. lol
Wow, Blue. You are going to town. lol
Bourbon, a negotiation now with finalization on approval would be meaningless, legally. Also, no BP is going to start ramping up for marketing and distribution based upon mere negotiations. However, signing an actual deal now with milestones and a distribution deal/revenue share upon approval would be a different story. With a chunk of cash up front, of course. Deal or no deal, those are the options. And I'm betting it will be deal.
Fair enough, Blue.
Blue, with all due respect, you sound like someone who is concerned about the stock taking off while you are out of position. A marked contrast to your previous tenor re ADXS.
Hey, Bomba, good to see you here. DOC's strategy certainly has always appeared to be to go for the homerun by going it alone as long as possible to maximize leverage upon the progression of trials. As FBG points out, though, we could have EU approval for AXAL-cervical within the next year, and ADXS and a BP cannot ramp up marketing and distribution instantaneously, so I believe DOC will understand that he needs a deal for at least that indication very soon, even if only for the EU. I could definitely see a deal for HOT as well, at roughly the same stage as NEO deal with Amgen.
What combo high dose Phase 2, Catt? And what leads you to that hypothesis?
The stock continues today to show unusual relative strength. Typically they they exaggerate the move of ADXS compared to the XBI and ADXS's peers, such as ADRO ZIOP. Not lately, though.
I'm not convinced, FBG, that it makes alot of sense to hold off on doing until a deal is struck, but I don't "get" why they do alot of things. For the record, I suspect a deal is coming either way.
You are trying to trade down too, Bourbon? lol. It's
Paul Ryan will do as Trump tells him? That seems like a dubious and premature conclusion.
ADXS is faring better than the XBI, and ADRO and ZIOP. Which is relatively unusual. As if someone is using weakness to cover/accumulate. It's been "relatively" strong the last few days also. Starting to wonder if some impending news really is in the works.
Well, regarding the fact that ADXS's vaccines will be cheap and thus its prices will not need to be negotiated, that is applying rational thought to the issue. The other side of the price control coin is that Trump wants to speed FDA approval, which also benefits a company like ADXS. However, traders don't care about such rational thought. This will pass soon, when it becomes clear that Trump is going nowhere with this plan.